250 ML tirofiban 0.05 MG/ML Injection [Aggrastat]
- RxCUI
- 1737472
- RxNorm name
- 250 ML tirofiban 0.05 MG/ML Injection [Aggrastat]
- Display name
- 250 ML tirofiban 0.05 MG/ML Injection [Aggrastat]
- Full name
- 250 ML tirofiban 0.05 MG/ML Injection [Aggrastat]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AGGRASTAT | TIROFIBAN | Medicure International Inc | fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f | 2025-01-01 | Warnings, Adverse reactions | 1737472 |
| AGGRASTAT | TIROFIBAN | Medicure International Inc | e850111f-e713-41a2-9c65-21c517cf5511 | 2025-01-01 | Warnings, Adverse reactions | 1737472 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f | AGGRASTAT 12.5 MG in 250 ML Injection [PSN] · 250 ML tirofiban 0.05 MG/ML Injection [Aggrastat] [SBD] · Aggrastat 12.5 MG per 250 ML Injection [SY] | 3 | 18 | These highlights do not include all the information needed to use AGGRASTAT® (tirofiban hydrochloride) safely and effectively. See full prescribing information for AGGRASTAT. AGGRASTAT (tirofiban hydrochloride) injection, for intravenous use Initial U.S. Approval: 1998 | 20250101 |
| e850111f-e713-41a2-9c65-21c517cf5511 | AGGRASTAT 12.5 MG in 250 ML Injection [PSN] · 250 ML tirofiban 0.05 MG/ML Injection [Aggrastat] [SBD] · Aggrastat 12.5 MG per 250 ML Injection [SY] | 3 | 3 | These highlights do not include all the information needed to use AGGRASTAT® (tirofiban hydrochloride) safely and effectively. See full prescribing information for AGGRASTAT. AGGRASTAT (tirofiban hydrochloride) injection, for intravenous use Initial U.S. Approval: 1998 | 20250101 |